← Back to catalogue

Monolisa™

FDA UDI

Class II (US FDA UDI)

by Bio-Rad Laboratories

Identity

Trade Name
MONOLISA™ FDA UDI
Generic Name
Hepatitis B virus core antigen IVD, reagent FDA UDI
Device Name
Anti-HBc EIA, Conjugate Reagent 30 mL FDA UDI
Model / Reference
26193 FDA UDI
Description
Anti-HBc EIA, Conjugate Reagent 30 mL FDA UDI

Identifiers

Catalog Number
26193 FDA UDI
Primary DI / UDI-DI
00847865013079 FDA UDI
PMA Number
P060031 FDA UDI
FDA Product Code
LOM FDA UDI
GMDN Term
Hepatitis B virus core antigen IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3172 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 30 Milliliter FDA UDI

Category: Hepatitis B virus core antigen IVD, reagent

Monolisa™ by Bio-Rad Laboratories — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Hepatitis B virus core antigen IVD, reagent.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 6315a596-24f5-4f4c-9022-944652beb3bc 38 fields · synced Jun 1, 2026